High Sp1/Sp3 Ratios in Epithelial Cells during Epithelial Differentiation and Cellular Transformation Correlate with the Activation of the HPV-16 Promoter  by Apt, Doris et al.
VIROLOGY 224, 281–291 (1996)
ARTICLE NO. 0530
High Sp1/Sp3 Ratios in Epithelial Cells during Epithelial Differentiation and Cellular
Transformation Correlate with the Activation of the HPV-16 Promoter
DORIS APT,* ROBIN M. WATTS,* GUNTRAM SUSKE,† and HANS-ULRICH BERNARD*,1
*Laboratory for Papillomavirus Biology, Institute of Molecular and Cell Biology, National University of Singapore, Singapore 0511;
and †Institut fu¨r Molekularbiologie und Tumorforschung, Philipps-Universita¨t Marburg, Germany
Received June 7, 1996; accepted August 7, 1996
Gene expression of human papillomavirus type 16 (HPV-16) and other HPV types is epithelial specific. Specificity is
brought about by synergism between several different transcription factors that seem to occur ubiquitously but differ
qualitatively and quantitatively between cells in which HPV genomes are transcriptionally active or inactive. Here, we report
on the contribution to this combinatorial mechanism by the activator Sp1 and the related antagonist Sp3, both of which
can bind a single site at the E6 promoter of all genital HPVs. In the Sp-factor-free background of Drosophila cells, Sp1
activates HPV-16 transcription, while Sp3 fails to do so and even inhibits the activation by Sp1. The same differential
activation occurs in the case of promoters of the epithelial-specific cellular genes encoding keratin 18 and E-cadherin. All
cell types that we examined contain similar amounts of Sp3 factor. In contrast, Sp1 levels, determined by supershifts and
Western blots, are higher in several human epithelial cell lines that support HPV transcription than in human fibroblasts,
liver, and muscle cells. This suggests that cell-type differential transcription is regulated by Sp1 and Sp3. In primary
keratinocytes, Sp3 levels exceed those of Sp1. This ratio became inverted after differentiating these cells in high calcium,
or methyl cellulose containing medium. The simultaneous transcriptional stimulation of the HPV promoter points to a role
of the Sp1–Sp3 antagonism during a differentiation of stratified epithelia in vivo, as these culture techniques mimick this
process in vitro. Transformation in vivo or in vitro seems to override these cell-type-specific controls and leads to a general
increase of Sp1 activity. q 1996 Academic Press, Inc.
INTRODUCTION genomes of different HPV types are so diverse that their
enhancer-promoter regions share no sequence similari-
The genital human papillomaviruses (HPVs) are a taxo- ties except a similar gross composition of short transcrip-
nomic group of about 50 HPV types that preferentially tion factor binding motifs, apparently a prerequisite for
infect mucosal and cutaneous epithelia of the genitals specific combinatorial mechanisms required for HPV
(de Villiers, 1994; Chan et al., 1995). The viral tropism for gene expression. This model requires a study of the tran-
epithelial cells seems to be mediated by transcriptional scriptional activation function of each of these factors
mechanisms, as the viral gene expression is cell-type- rather than their DNA binding properties.
specific (Cripe et al., 1987; Gloss et al., 1987) while the Independent research into the epithelial-specific tran-
infection is apparently a promiscuous process (Roden et scription of cellular genes such as those encoding the
al., 1994; Mu¨ller et al., 1995). keratins 5, 7, 14, 18, as well as E-cadherin has led to
The studies of this mechanism concentrated on HPV- complementary observations, as their promoters and en-
11, HPV-16, and HPV-18, and localized on the respective hancers are not activated by epithelial specific but rather
500-bp enhancer-promoter segments about 20 cis-re- by ubiquitous factors (Glass and Fuchs, 1988; Kulesh et
sponsive elements that are bound by up to 10 different al., 1988; Vassar et al., 1989; Leask et al., 1990; Behrens
transcription factors (Fig. 1; see O’Connor et al., 1995, et al., 1991; Casatorres et al., 1994; Lu et al., 1994; DiSe-
for a review and references). DNA binding studies sug- pio et al., 1995). Interestingly, factors that activate HPV
gest that all of these factors occur in both epithelial and transcription also play a prominent role in the epithelial-
nonepithelial cells, while mutational studies suggest that specific expression of these genes, with AP-1, NFI, and
several of these factors activate the enhancer-promoter Sp1 binding sites as particularly conspicuous motifs in
exclusively in epithelial cells, thus one has to conclude genital HPVs and cellular epithelial-specific genes alike.
that epithelial-specific functions are provided by ubiqui- Epithelial-specific functions of AP-1 and NFI have
tously binding factors. Further support for this assump- emerged from the finding that these factors exist as ho-
tion comes from nucleotide sequence comparisons. The mo- and heterodimers, which are composed of subunits
derived from multigene families, and major differences
in the composition of these factors were found in epithe-1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (65) 779-1117. E-mail: mcbhub@leonis.nus.sg. lial and nonepithelial cells. The function of AP-1 factors
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can vary as the jun- and fos-gene family provides sub- nism plays an important role in epithelial- and differentia-
tion-specific activation of the HPV-16 promoter as wellunits for AP-1 with similar DNA binding but different acti-
vation potential (Thierry et al., 1992; for reviews see Angel as during transformation. It is likely that our findings have
relevance beyond HPV biology, as additional data predictand Herrlich, 1994). NFI factors are products of a
multigene family that includes a negative regulator de- a similar impact of Sp-factors on the expression of the
cellular epithelial proteins keratin 18 and E-cadherin.rived from the NFI-X gene (Apt et al., 1993, 1994). This
negative regulator is highly expressed in fibroblasts but
absent or expressed poorly in epithelial cells. MATERIALS AND METHODS
In HPV gene expression, Sp1 has so far drawn atten-
Plasmidstion as an activator that binds a single site close to the
E6 promoter (Gloss et al., 1990; Hoppe-Seyler and Butz, The chloramphenicol acetyl transferase (CAT) reporter
1992; Dollard et al., 1993). This site has two functions, construct p16, which contains the HPV-16 E6 promoter
namely to mediate E6 promoter activation by the remote p97, has been described (O’Connor et al., 1995). The
enhancer and to provide transcriptional feedback repres- plasmids p16-e91 and p16-e232 were derived from p16
sion, as the viral E2 protein can displace Sp1 as well as by cloning a 91-bp BamHI–HindIII fragment with the
TFIID from overlapping binding sites of the E6 promoter HPV-16 core enhancer (footprints fp4e-fp6e, genomic po-
(Dostatni et al., 1991; Tan et al., 1994; Dong et al., 1994). sition 7629–7719) or a 232-bp DraI fragment, respectively
Sp1 binds to GC boxes and similar motifs, and has (Chong et al., 1991) in front of p97. Figure 1 represents
long been thought to be the only factor acting through the organization of the HPV-16 long control region and
these sites (Kadonaga et al., 1986, 1987). These motifs highlights the tested segments. The construct XKCATspa ,
have been identified as cis-responsive elements in ubiq- which contains the keratin 18 gene promoter (Kulesh and
uitously active promoters, such as those of the herpes Oshima, 1988), was the kind gift of R. G. Oshima, and
simplex virus thymidine kinase and simian virus 40 the E-cadherin promoter construct of W. Birchmeier and
(SV40) T antigen genes (Pascal and Tjian, 1991). Sp1 did J. Behrens (Behrens et al., 1991). The NFI-C and NFI-X
not appear to be a component of a regulatory pathway, expression plasmids p113-CTF-1 (Martinez et al., 1991)
although it had been observed that the Sp1 protein can and pXJ-NFI-X1, and plasmids for Sp1 and Sp3 expres-
become phosphorylated and glycosylated and might thus sion in Drosophila SL-2 cells, pPacSp1 and pPacSp3,
be a target of intracellular signalling (Jackson and Tjian, have been described (Apt et al., 1993, 1994; Hagen et
1988; Jackson et al., 1990). The view of Sp1 as a mediator al., 1994). For RNAse protection assay the OVEC Vector
of constitutive activation had to be revised, however, system was used. The OVEC vector consists of a b-
when it was recently found that Sp1 is only one among globin gene with a upstream consensus TATA box
four related transcription factors derived from a cloned in pUC18. The OVEC-Ref plasmid contains the
multigene family. Sp2, which binds a GT box in the pro- SV40 enhancer upstream of the TATA box. OVEC-Ref and
moter of a T-cell receptor gene, seems to have divergent the antisense construct pSP6bTS were both constructed
nucleotide sequence recognition properties (Kingsley in the laboratory of Walter Schaffner (Westin et al., 1987).
and Winoto, 1992), while Sp3 (Hagen et al., 1992, 1994; The construction of the SVe/HPVp-OVEC vector, which
Kingsley and Winoto, 1992) and Sp4 (Hagen et al., 1995) replaces the consensus TATA box with the HPV-16 pro-
have binding specificities similar to those of Sp1. All moter sequence, which contains a binding site for the
factors contain a highly conserved zinc finger DNA bind- cellular transcription factor Sp1 additionally to a TATA
ing domain and glutamine-rich activation domains. While box, is described elsewhere (Gloss et al., 1990).
this initially suggested similar functions, subsequent
studies found that only Sp1 and Sp4 could activate differ- Cell culture, transfection, CAT assays
ent test promoters, while Sp3 had inhibitory functions
(Hagen et al., 1994, 1995). These new findings concern- The human epithelial cell lines HeLa, C33A, and HaCat
(Boucamp et al., 1984), and the human fibroblast lineing Sp-factors raised the question of whether or not GC
boxes constitute another example of regulation through MRHF have been cultured in our lab for many years
(Chong et al., 1991). HeLa and C33A cells had beencis-responsive elements that were originally miscon-
ceived as having constitutive functions just because DNA derived from cervical carcinomas and have maintained
a phenotype representing their epithelial origin (Quinlanbinding can be observed in a variety of commonly used
cell lines. et al., 1985). The human liver cell line HS168 (ATCC, CRL
7137), the human smooth muscle line HISM (ATCC, CRLThe antagonism between Sp1 and Sp3 has been
mechanistically studied (Hagen et al., 1994); however, its 1692), the human lung fibroblast line MRC5 (ATCC, CCL
171), and its SV40 large T antigen-transformed derivatebiological consequences remained unknown. Here, we
investigated whether the complexity of the Sp-transcrip- MRC5 SV1 TG1 (ECACC 85042501) were commercially
available. To simplify the nomenclature, we refer to thistion factor family has consequences for the transcription
of papillomaviruses, and found that the Sp1–Sp3 antago- latter cell line here as MRC5/SV. All cells were cultured
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FIG. 1. Genomic segments of the long control region (LCR) of HPV-16, which were tested in this research (bold bars in lower part of the figure).
For a review of the functions (arrows in the upper part of the figure), transcription factor binding sites (central part) and a complete list of citations
see O’Connor et al. (1995). The promoter segment in p16 has a size of 65 bp and stretches between the genomic positions 16 and 80 of HPV-16.
It has no known transcription factor binding sites except a GC box, two E2 binding sites, and a TATA box and has a highly similar composition in
all genital HPV types (Tan et al., 1994). The enhancer constructs p16-e91 and p16-e232 contain additional enhancer segments with lengths of 91
and 232 bp. These two constructs differ in activity but not in their known biological property, the stimulation of epithelial-specific transcription in
the context of GC box containing promoters. The segment that is deleted in both plasmids contains the viral replication origin as well as a strong
silencer with several YY1 binding sites. Abbreviations: AP-1, activator protein 1; cEBP, enhancer binding protein; E1, HPV replication factor E1; E2,
HPV transcription factor E2; GR/PR, glucocorticoid and progesteron receptors; NFI, nuclear factor I; oct, octamer binding factor 1; pA, polyadenylation
site of L1 transcript; TF1 and TF2, transcriptional enhancer factor 1 and 2; TIC, transcription initiation complex; YY1, Ying and Yang factor 1.
by standard procedures (Chong et al., 1991; Apt et al., 42 hr after transfection. For CAT assays, 20 mg protein
were used after transfection with p16 and p16-e91, while1994). Primary human foreskin keratinocytes (Cascade
Biologics Inc.) were cultured in serum-free keratinocyte 50 mg protein were used in case of pXKCATspa .
medium (Keratinocyte-SFM, GIBCO BRL) according to the
manufacturer’s recommendation. These keratinocytes Nuclear extracts, DNA binding assays, and Western
were induced to differentiate by placing them either in blotting
SFM-medium containing 1.2 mM CaCl2 (Hennings et al.,
1980) or in suspension culture in medium containing Nuclear extracts were prepared according to
Schreiber et al. (1989). About 106 cells were used for1.75% methyl cellulose (Green, 1977). For CAT assays,
keratinocytes were transfected with the Lipofectin Re- each preparation and nuclear proteins were dissolved in
a final volume of 50 ml. Bandshift assays were performedagent (Gibco, BRL). Cells were grown in 100-mm plates
and 6 ml fresh medium were added prior to transfection. as described (Chan et al., 1990), with 3 mg of poly (dl-
dC) used as nonspecific competitor, and 5 mg protein forFive micrograms of the reporter plasmids p16-e91 and
p16-e232 in 0.5 ml medium were mixed with 0.5 ml me- each binding reaction. Oligonucleotides were radioac-
tively labeled by filling 3* recessed termini (four basep-dium containing 30 ml lipofectin and incubated for 15 min
prior to addition to the cells. Cells were left on lipofectin airs) with Klenow DNA polymerase. Their sequences (se-
quence of the upper strand after fill-in) were 5*-TCGATC-for 18 hr, washed, transferred into medium containing
1.75% methyl cellulose for differentiation, and further in- CGTTGGGGCGGGGCTTCACGTCGA-3* for the GC box
and for fp2u 5*-TCGAACTAAGGGCGTAACCGAAATCGG-cubated for another 30 hr. After 48 hr, cells were har-
vested and 40 mg of protein were used for CAT assays TTG-3*. For supershifts, the nuclear extracts were first
incubated with competitor and the labeled oligo for 15which followed standard procedures (Chong et al., 1991).
Drosophila Schneider SL-2 cells were grown and min on ice, and then with 1 ml of the anti-Sp1 antibody
(Santa Cruz SC-59) or anti-Sp3 antibody (Hagen et al.,transfected as described (Apt et al., 1993). The cells were
plated at a density of 106 cells/ml and transfected with a 1994) for another 30 min at room temperature before
separation on a 4.5% polyacrylamide gel.total of 15 mg DNA using pUC19 plasmid DNA as carrier.
Reporter plasmids p16 and XKCATspa (7 mg) were cotrans- Western blotting was carried out as described (Apt et
al., 1993). Thirty microliters of nuclear extracts containingfected with 0.2–3 mg of the effector plasmids pPacSp1
and pPacSp3. The reporter plasmid p16-e91 was cotran- identical amounts of protein were separated in an 8%
SDS/polyacrylamide gel and electroblotted to a nitrocel-sfected with 0.5–2 mg pPacSp1 or pPacSp3 and 3 mg
p113-CTF-1 and pXJ-NFI-X1. Cells were harvested 40– lulose membrane. After processing of the blots with an
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anti-Sp1-antibody (Santa Cruz SC-59) at 1:1000 dilution,
complexes were detected with the ECL-Western blotting
analysis system (Amersham).
RNAse protection analysis
MRC5 and MRC5/SV cells were transfected by the
calcium phosphate coprecipitation procedure (Gloss et
al., 1987) with 10 mg reporter plasmid SVeHPVp-OVEC, 2
mg reference plasmid OVEC-Ref, and 8 mg pUC19 carrier
DNA. The cells were harvested 42 hr after transfection
and total RNA was extracted using TRIzol reagent
(GIBCO BRL) according to the manufacturer’s recommen-
dation. Total RNA (10 mg) was used for hybridization to
a radioactive complementary strand RNA that had been
generated by SP6 polymerase according to the manufac-
turer’s recommendation (Riboprobe Gimini II core sys-
tem, Promega). Hybridization and RNAse digestion were
performed using the RNAse Protection Assay System
(Promega). The hybrids were separated on a 6% poly- FIG. 2. Gel shift analysis of the binding of Sp1 and Sp3 to different
DNA recognition sequences. Binding of Sp-factors present in HeLaacrylamide/7 M urea gel, and radioactive incorporation
nuclear extracts to a classical GC box (lane 1 to 6) and the aberrantquantified with the integrated volume function of a Phos-
HPV-16 promoter sequence, fp2u (lane 7 to 11). The upper band con-phorimager. Details of the evaluation of signals as ob-
tains both Sp1 and Sp3 complexes (see also Fig. 2), the lower band
tained by OVEC constructs, including the nature of a (Sp3ò) a N-terminal truncated form of Sp3. Competition of these bands
shorter transcript derived from OVEC-Ref due to a 28-bp with the homologous GC box oligo (lanes 2 and 3) or fp2u oligo (lanes
8 and 9) as well as the heterologous oligonucleotides (lanes 4 to 6deletion around the transcription start site, have been
and 10 and 11).described (Westin et al., 1987; Gloss et al., 1990).
2 represents both Sp1- and Sp3-complexes. This as-RESULTS
sumption is confirmed by a supershift analysis (Fig. 3
The aberrant GC box of the HPV-16 promoter does and see below). The fast migrating Sp3 complex (labeled
not select for a specific Sp-factor here Sp3ò) results from binding of a N-terminal truncated
form of Sp3 with a complete DNA binding but a partiallyAll genital HPV types have an Sp1 binding site cen-
deleted activation domain (Hagen et al., 1992, 1994; G.tered about 65 bp upstream of the transcription start site
Suske, unpublished results). The predicted open readingof the E6 gene (Tan et al., 1994; O’Connor et al., 1995).
frame of the Sp3 cDNA, which encodes a 100-kDa pro-In the case of the p97 promoter of HPV-16, DNAse I
tein, does not start with an ATG. Due to the weak transla-protection assays had originally identified this site as a
tion start site, the next ATG about 400 bp downstreamfootprint (fp2u) on the hexamer GGGCGT (Gloss et al.,
is apparently used as suggested also by the appearance1990), an aberrant sequence compared to the classical
of both polypeptides after expression of the Sp3 cDNAGGGCGG motif (Kadonaga et al., 1986). As all HPVs
in SL-2 cells (data not shown). In summary, Sp3 is ex-seem to have aberrant GC boxes (Tan et al., 1994), we
pressed in form of two proteins, a full-size form with aasked whether or not these sequences would have differ-
nonfunctional region homologous to the Sp1 activationent relative affinities to the different Sp-factors.
domain and a truncated form without a functional activa-Figure 2 shows a gel shift competition assay with nu-
tion domain.clear extracts from HeLa cells and a classical GC box
Competition analysis shows that fp2u binds both com-(lanes 1 to 6) and the fp2u sequence of HPV-16 (lanes 7
plexes qualitatively similar to a GC box but with lowerto 11) as recognition sequences. Both oligos are bound
affinity. Competitor GC box oligo (20 ng) could competeby two protein complexes in similar relative ratios. The
for both the GC box (Fig. 2, lane 3) and the fp2u oligo (lane
complex with the slower mobility is more abundant than
10), while more than 50 ng of fp2u oligo were needed to
the complex with the faster mobility (lanes 1 and 7). Ear-
compete with itself (lane 9) and more than 100 ng to
lier supershift analyses with anti-Sp1 and anti-Sp3 anti-
compete the GC box efficiently (lane 6).
bodies have shown that Sp1 and Sp3 complexes run in
Epithelial cells express higher levels of the activatorsimilar positions and often overlap, although within this
Sp1 than fibroblastsoverlap, Sp1 complexes have a slightly lower mobility
than Sp3 (Hagen et al., 1994). Our gel shift conditions do The epithelial specificity of the HPV-16 enhancer-pro-
moter is derived from the actions of seemingly ubiquitousnot separate the two bands, thus the upper band in Fig.
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FIG. 3. Differences in Sp1 and Sp3 binding activities in extracts from human HeLa epithelial cells (H) and human MRHF fibroblasts (M). (A) Gel
shift analysis with nuclear extracts from HeLa cells (lane 1) and MRHF cells (lane 2) to the GC box motif. Antibodies specific for Sp1 or Sp3 in a
supershift analysis determine the relative levels of Sp1 and Sp3. The anti-Sp1 antibody shifts Sp1 out of the overlapping band, allowing monitoring
of the binding of Sp3 by the intensity of the residual bands (lanes 3 and 4). Supershift with the anti-Sp3 antibody shows the amount of Sp1 binding
in form of the residual band (lanes 5 and 6). (B) Supershift analysis with the HPV-16 fp2u oligonucleotide motif. (C) In a control experiment with
the fp2u oligo, both antibodies together shifted the Sp-binding activities in HeLa (lane 2) and MRHF cells (lane 3) with the same efficiency. (D)
Western blot with anti-Sp1 antibody and nuclear extracts from epithelial cells lines (C33A, lane 1; HeLa, lane 2) and fibroblasts (MRHF, lane 3;
MRC5, lane 4).
transcription factors. To address the question whether firmed by using SiHa, C33A, and HaCat epithelial cells
and MRC5 fibroblasts (see below). Other human cell linesthe Sp1-Sp3 system is part of this combinatorial process,
we analyzed the ratio between these two factors with where the viral promoter is inactive, like HISM primary
smooth muscle cells and HS168 primary liver cells,specific antibodies against Sp1 and Sp3 in Hela epithe-
lial cells, where HPV-16 is transcriptionally active, in showed also very low levels of Sp1 compared to Sp3
(data not shown).comparison to MRHF fibroblasts, which do not support
HPV-16 transcription. To study whether the higher levels of Sp1 in epithelial
cells in comparison with fibroblasts were due to a higherFigure 3A shows Sp-proteins in nuclear extracts from
HeLa cells (lane 1) and MRHF cells (lane 2) binding to expression level or to different binding activities, we per-
formed a Western blot analysis of these two cell types.the GC box motif, and Fig. 3B binding to the HPV-16 fp2u
motif. Within the band migrating at slower mobility, the Figure 3D shows that Sp1 levels in the epithelial cells
C33A and HeLa (lane 1 and 2) are significantly higherposition of Sp1 and Sp3 complexes is indicated, while
the fast migrating band, containing the truncated form of than those in the fibroblast lines MRHF and MRC5 (lane
3 and 4), while there were equal amounts of Sp3 in allSp3, is marked Sp3ò. While the combined Sp1-Sp3 band
is more intense with HeLa extracts, the Sp3ò band has four cell types (data not shown).
a similar intensity in both cell lines (compare Figs. 3A
and 3B, lanes 1 and 2). The supershift with the anti- Functional importance of different Sp1/Sp3 ratios for
Sp1 antibody identifies the amount of Sp3 in form of HPV-16 promoter activity
the residual label running in the position of the slower
migrating band and the truncated form in the faster mi- To determine the role of the observed differences of
Sp1 versus Sp3 levels in different cell types on the genegrating band. The similar intensities indicate that Sp3
has similar concentrations in HeLa and MRHF cells (Figs. expression of papillomaviruses, we measured the influ-
ence of both factors on the HPV-16 promoter in Drosoph-3A and 3B, lanes 3 and 4).
The anti-Sp3 antibody revealed that the Sp1 binding ila SL-2 cells. SL-2 cells contain the basic machinery for
transcription, but lack some transcription factors like Sp1activity is much higher in Hela cells than in fibroblasts
(compare the residual bands in Figs. 3A and 3B, lanes (Courey and Tjian, 1988), facilitating the study of defined
concentrations of Sp1 and Sp3 on promoter activity in5 and 6). Both antibodies were used together to show
that no other form of Sp-transcription factor is present in an otherwise identical cellular background. The HPV-16
promoter construct p16 was cotransfected into SL-2 cellsHela extracts (Fig. 3C, compare lanes 2 and 3). This was
further confirmed with antibodies against Sp2 and Sp4 with vectors expressing either Sp1, or Sp3, or a combina-
tion of these two vectors. The expression of Sp1 and Sp3which did not lead to a visible reduction of the complexes
(data not shown). The finding, that epithelial cells contain was evaluated by gel shift analysis (Hagen et al., 1994,
and data not shown). The CAT assays in Fig. 4A, lane 1,higher levels of Sp1 than fibroblast cells was further con-
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of the NFI-C family activate the viral enhancer, while NFI-
X1, a member of the NFI-X family, fails to do so (Apt et al.,
1994). Figure 4B (lane 1) shows the activity of the HPV-16
enhancer-promoter construct under the influence of endog-
enous AP-1 alone. Coexpression of NFI/CTF-1 and Sp1 led
to an 11-fold stimulation (lane 2), while, as we have shown
earlier (Apt et al., 1994), NFI/CTF-1 alone stimulated the
HPV-16 core enhancer only 2- to 3-fold. The transcription
factors Sp3 and NFI-X1, which inhibit the transactivation of
Sp1 and NFI-C, barely altered the activity (1.3-fold, lane 3),
while a combination of the activator NFI/CTF-1 and the
repressor Sp3 (lane 4) or the repressor NFI-X1 and the
activator Sp1 (lane 5) stimulated transcription only weakly
(2.7-fold and 3.5-fold, respectively). We conclude from this
that in the transcriptional environment of SL-2 cells HPV-
16 enhancer-promoter activity is high under the influence
of a combination of those Sp- and NFI-transcription factors
that predominate in HeLa and other epithelial cells, while
the activity is low under the influence of transcription fac-
tors, whose relative concentration is high in MRHF and
other fibroblasts.
The Sp1–Sp3 antagonism modulates transcription of
the genes encoding keratin 18 and E-cadherin
FIG. 4. Modulation of the HPV-16 promoter by Sp1 and Sp3 in Dro- Since many cellular genes that are specifically ex-
sophila SL-2 cells. SL-2 cells were cotransfected with a two reporter pressed in epithelial cells have promoters with GC
constructs either containing the HPV-16 promoter alone (p16; A) or the boxes, we decided to include in this study the E-cadherin
HPV-16 enhancer-promoter (p16-e91; B) and expression vectors for the
promoter (Behrens et al., 1991) and the keratin 18 pro-transcription factors Sp1, Sp3, NFI/CTF, or NFI-X1. (A) Activity of the
moter (Kulesh and Oshima, 1988). The activation of theHPV-16 promoter in the absence of Sp factors (0), or cotransfected
with 500 ng Sp1 or Sp3 expression vector or a combination of the two, keratin 18 promoter in cotransfection of SL-2 cells is
with 500 ng of Sp1 and 1 mg of Sp3. (B) Activity of the HPV-16 enhancer- shown in Fig. 5. The promoter, which has four potential
promoter alone (0) or under the influence of the four different transcrip- Sp1 binding sites, could be stimulated 17-fold by Sp1
tion factor expression clones. The relative stimulation values were cal-
(lane 2) while Sp3 failed to activate transcription (lane 3).culated from the CAT activities determined in four independent experi-
A twofold excess of Sp3 over Sp1 reduced the activationments.
potential of Sp1 about threefold (lane 4). The E-cadherin
promoter, which contains a single potential Sp1 binding
show the HPV-16 promoter activity without Sp1 factor
activation. This activity could be stimulated by Sp1 5.6-
fold (lane 2), while Sp3 failed to activate the promoter
(lane 3). Coexpression of Sp1 with different levels of Sp3
reduced the activation potential of Sp1. The data of this
particular experiment show that a twofold excess of Sp3-
expression vector reduced the activation by Sp1 about
twofold (lane 4).
Since Sp1 and Sp3 may have different activation potential
in combination with the cis-responsive elements specific
for the viral enhancer, we decided to study the HPV-16 p97
promoter in the presence of the viral core enhancer. This
enhancer is activated by several transcription factors, with
AP-1 and NFI playing a prominent role (Chong et al., 1990, FIG. 5. Activity of the keratin 18 promoter under the influence of Sp1
and Sp3 expression in Drosophila SL-2 cells. SL-2 cells were trans-1991). Since SL-2 cells express endogenous AP-1 proteins
fected with the keratin 18 promoter reporter plasmid, XKCATspa, alonebut not NFI (Perkins et al., 1990), we supplemented NFI
(0), or cotransfected with 500 ng of the expression vectors for Sp1 and
proteins by cotransfection of NFI expression vectors. Spe- Sp3, or a combination of the two (500 ng of Sp1 and 1 mg of Sp3). The
cifically, we chose two spliced variants of the NFI-C and relative stimulation values were derived from CAT activities determined
in four independent experiments.NFI-X family, as we have previously shown that members
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FIG. 6. Quantitative comparison of Sp1 and Sp3 binding activities in different human epithelial cells which do not harbor endogenous HPVs. (A)
of a GC box oligo with nuclear extract from HaCat (lane 1) and C33A cells (lane 4). A supershift with the anti-Sp1 antibody reveals the amount of
Sp3 in HaCat (lane 2) and C33A extracts (lane 5). A supershift with the anti-Sp3 antibody (lanes 3 and 6) identifies the binding of Sp1. (B) Supershift
analysis of Sp1 and Sp3 factors in primary human keratinocytes (lanes 1 to 3) and after induction by calcium for 8 hr (lane 4 to 6) or by methyl
cellulose for 16 hr (lane 7 and 8).
site, similar to the genital HPVs, was fourfold stimulated cium can be followed visually by observing changes of
morphology and growth behavior (Green, 1977; Henningsby 500 ng of Sp1 expression vector, while various
amounts of Sp3 expression vector failed to stimulate this et al., 1980). The process of differentiation by methylcellu-
lose was confirmed by enhanced involucrin expressionpromoter (data not shown).
and an increase of cross-linked envelopes, a score for
Sp1 is expressed at high levels in several epithelial terminally differentiated cells (data not shown). Figure 6B
cell lines and is up-regulated during differentiation of shows the levels of Sp3 (lane 5) and of Sp1 (lane 6) 8 hr
primary keratinocytes after induction of differentiation by calcium and 16 hr after
induction of differentiation by methyl cellulose (lanes 7The observation that a high Sp1/Sp3 ratio is important
and 8). Both experiments show that the levels of thefor a strong activity of several epithelial cell-specific pro-
activator Sp1 are strongly up-regulated during differentia-moters prompted us to examine if the high levels of Sp1
tion in vitro, while the levels of the repressor Sp3 areobserved in HeLa and Siha cells is a general characteris-
slightly down-regulated. As an additional control that thetic of epithelial cells. It has been published that SV40 T
up-regulation of Sp1 was due to differentiation ratherantigen can stimulate the level of Sp1 mRNA (Saffer et
than a result of downstream effects of any ubiquitousal., 1990). Since Hela and SiHa cells both express the
signalling pathway triggered by calcium ions, we culturedHPV E6 and E7 oncoproteins, which might exert a similar
MRHF fibroblasts in high calcium medium. No up-regula-effect, we included in our study three other epithelial cell
tion of Sp1 was observed in these cells (data not shown).types, namely primary keratinocytes, the spontaneously
immortalized keratinocyte line HaCat, and the cervical
HPV-16 transcription is up-regulated in differentiated
carcinoma cell line C33A, which does not contain endog-
keratinocytes
enous HPV genomes. Figure 6A shows the Sp1 and Sp3
protein binding activities in HaCat (lane 1) and C33A To test the functional consequence of the increase of
Sp1 levels during differentiation, we studied the activitycells (lane 4). Both cell lines contain high levels of Sp1
(lanes 3 and 6) compared to the levels of Sp3 (lanes 2 of the HPV-16 promoter in undifferentiated keratinocytes
and after induction of differentiation. Figure 7A showsand 5), evidence that high Sp1 levels are not primarily
derived from the presence of HPV gene products. the activity of the HPV-16 promoter construct p16, which
contains a TATA box and the Sp1 binding site, beforeIn case of primary keratinocytes (Fig. 6B), the Sp1 bind-
ing activity (lane 3) was found to be lower than that of (lane 1) and after differentiating the keratinocytes by cul-
ture for 30 hr in the presence of methyl cellulose (lane 2).Sp3 (lane 2). Cellular markers as well as the ability of
these cells to divide indicate that these primary cultures Through differentiation of the keratinocytes, p16 activity
increased 2.5-fold. The stimulation value (Fig. 7A, upperare largely composed of undifferentiated cells. To deter-
mine whether the Sp1/Sp3 ratio may be under physiologi- panel) was calculated from three independent experi-
ments. To examine whether the upregulation of the HPV-cal regulation, we induced differentiation of these cells
by two established procedures, namely either by growing 16 promoter is influenced by factors binding to the viral
enhancer, we repeated this experiment with the en-the cells as a suspension in methyl cellulose containing
medium or by raising the concentration of extracellular hancer-promoter construct p16-e232. This enhancer frag-
ment contains all the relevant transcription factor bindingcalcium. The process of differentiation induced by cal-
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et al., 1987), SVe/HPVp-OVEC, which permits measure-
ment of the correct expression of a b-globin transcript
under the control of the HPV-16 promoter and the SV40
enhancer compared to the SV40 enhancer and a consen-
sus TATA box (OVEC-Ref). SVe/HPVp-OVEC and OVEC-
Ref were cotransfected into MRC5 and MRC5/SV cells,
and the amount of correctly initiated b-globin RNA tran-
FIG. 7. HPV-16 promoter activity in undifferentiated and differentiated
keratinocytes. CAT assays determined the promoter activity of the re-
porter constructs p16 with the HPV-16 promoter (A) and p16-e232 with
the HPV-16 promoter and a 232-bp HPV-16 enhancer fragment (B) in
keratinocytes before (lanes 1) and 30 hr after induction of differentiation
by methyl cellulose (lanes 2). The upper panels show the quantification
of CAT assays from three independent experiments before (light bars)
and after differentiation (black bars) in picomoles per minute per milli-
gram of protein.
sites which have been shown to contribute to enhancer
activity, but misses the YYI binding sites with repressing
function (see Fig. 1). Figure 7B shows that the activity
of the viral enhancer/promoter increased 3.5-fold during
differentiation. The slightly higher stimulation value may
result from the contribution of one of the enhancer bind-
ing factors.
The activity of HPV-16 promoter is increased by a
FIG. 8. Functional consequence of altered Sp1/Sp3 ratios in trans-high endogenous Sp1/Sp3 ratio in transformed cells
formed cells. (A) Gel shift analysis of a GC box oligo with nuclear
extracts from the human fibroblast cell line MRC5 (lane 1) and theSince primary keratinocytes have lower levels of Sp1
SV40-transformed derivative MRC5/SV (lane 4). Supershift with an anti-than transformed epithelial cells, we asked whether
Sp1 antibody reveals the amount of Sp3 in MRC5 (lane 2) and MRC5/transformation can up-regulate the levels of Sp1 and the
SV extracts (lane 5). Lanes 3 and 6 document the binding of Sp1 in
HPV promoter activity. Toward this question, we com- MRC5 and MRC5/SV using the anti-Sp3 antibody. (B) HPV-16 promoter
pared untransformed fibroblasts (MRC5) with a SV40 T- activity in human MRC5 cells with different endogenous Sp1/Sp3 ratios.
Quantitative RNAse protection analysis of b-globin RNA expressedantigen-transformed derivative (MRC5/SV). Figure 8A
from the reporter construct SVeHPVpOVEC (HPV-16 promoter and SV40shows that the level of Sp1 in MRC5 is strongly up-
enhancer) and the reference plasmid OVEC-Ref (SV40 enhancer andregulated after transformation by the SV40 T-antigen
TATA-box) in MRC5 and MRC5/SV cells. The label b-init identifies cor-
(compare lane 3 and 6), confirming previous observations rectly initiated b-globin RNA from the reporter SVeHPVpOVEC (b-init)
for other cell systems (Saffer et al., 1990). The levels of in MRC5/SV cells, which express high levels of Sp1 (lane 1) and from
MRC5 cells, which express low levels of Sp1 (lane 2). The label refSp3 are not drastically affected (lane 2 and 4). The discov-
identifies RNA derived from OVEC-Ref that serves as an internal control.ery that MRC5 and MRC5/SV cells express different lev-
A sequencing lane was used as a size marker (not shown). (C) Quantifi-els of Sp1 offered another transcriptional environment to
cation of the signals as determined by a PhosporImager. The activity
confirm the dependence of the HPV-16 promoter activity numbers are arbitrary units of the signals from the reporter gene (b-
on a high endogenous Sp1/Sp3 ratio. As a reporter sys- init) relative to those from the reference plasmid (ref), and were calcu-
lated from four independent transfection experiments.tem we used a derivate of the OVEC plasmids (Westin
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scribed was determined by quantitative RNAse protec- in cell types where the HPV-16 promoter is active, and
very low levels in cells, where it is inactive. Based ontion. To determine the influence of the Sp1 binding site
in the HPV-16 promoter the values found for SVe/HPVp- these observations we propose that the Sp1–Sp3 antag-
onism is one module of complex combinatorial mecha-OVEC were standardized against the values obtained for
OVEC-Ref. Figure 8B, lane 1, shows the correctly initiated nisms that activate HPV gene expression (i) specifically
in epithelial cells, (ii) during differentiation of stratifiedtranscript from the reporter construct (b-init) in MRC5/
SV, where Sp1 is highly expressed, and in the parental epithelia, and (iii) during the progression of the trans-
formed state of HPV-infected cells.line MRC5 (lane 2), which expresses low levels of Sp1,
but high levels of Sp3. Figure 8C shows the quantification Over the last decade epithelial-specific transcription
of several different HPV types (for a recent review seeof the signals of the reporter construct (black bars) versus
the reference plasmid (gray bars) in both cell lines. The O’Connor et al., 1995) and about 10 different cellular
genes (for review see introduction) has been intenselycombined activity of the SV40 enhancer with HPV-16 fp2u
is 1.3-fold higher in MRC5 cells than that of the SV40 studied, but surprisingly, no epithelial-specific transcrip-
tion factor has been detected. The most promising hy-enhancer alone, but 3.9-fold higher in MRC5/SV cells.
Thus, the increase of Sp1 over Sp3 led to a 3-fold stimula- pothesis to unravel this paradox seems to be to search
for cell-specific functions in seemingly ubiquitous tran-tion of HPV-16 promoter activity. These findings also ex-
clude the possibility that the antagonistic function of Sp1 scription factors. This search has gained a strong foot-
hold by observations that many cis-responsive elementsand Sp3 observed in Drosophila SL-2 cells may originate
from some artifactual properties of the Sp1 and Sp3 ex- are recognized not by single factors, but rather by a set
of related factors, that may act positively or negativelypression vector, as it can be observed in human cell
lines directly as a consequence of the activity of the on transcription (for a review see Latchmann, 1991). Pro-
posals of how this may lead to epithelial-specific func-endogenous transcription factors.
tions of the AP-1 and NFI families of transcription factors
have been published (Thierry et al., 1992; Apt et al., 1993).DISCUSSION
Here, we propose, that the Sp1–Sp3 pair is an important
module of synergistic mechanisms that generate epithe-It has long been thought that Sp1 is the only factor
acting on GC boxes (Kadonaga et al., 1986, 1987). How- lial-specific transcription. We also observed a strong cor-
relation between high levels of Sp1 and HPV-16 tran-ever, during recent research three transcription factors,
Sp2, Sp3, and Sp4, were identified that are related to scription during differentiation of stratified epithelia. Our
data are supported by the recent finding that in raft cul-Sp1 (Hagen et al., 1994, and references therein). The
factors are expressed in many cell types in culture, while tures as well as in several patient specimens containing
HPV-6, HPV-11, HPV-16, and HPV-18 genomes the E6–in vivo, Sp4 seems to be brain-specific (Hagen et al.,
1995). In spite of the similarities of the primary amino E7 genes were upregulated during differentiation (Cheng
et al., 1995). In condylomata one also finds higher expres-acid sequences of all factors, Sp3 is, in contrast to Sp1
and Sp4, unable to activate transcription and functions sion of HPV-6 and HPV-11 in differentiated cells than in
the basal layer (Stoler et al., 1989). Last, GC boxes mayas a repressor, probably due to competition with Sp1 for
the same binding sites. While data describing principles lead to strong activation of HPV transcription in trans-
formed cells, a proposal paralleled in the Sp1-dependentof this mechanism were published (Hagen et al., 1994),
its biological relevance remained obscure. Here, we overexpression of keratin 18 in certain tumor cells
(Gunther et al., 1995). This proposal may also explainhave used the HPV-16 E6-E7 gene promoter p97, which
serves as a model for the homologous promoters of all the frequent detection of keratin 18 in squamous cell
carcinomas of the cervix, which are derived from epithe-genital HPVs, to study important biological functions of
the Sp1–Sp3 pair. lia which express keratin genes other than keratin 18
prior to tumor progression (Smedts et al., 1993).We have found that the two factors provide a powerful
mechanism of transcriptional regulation of p97, as in SL- We do not see a conflict between our proposal and
the view that GC boxes also play a role in the expression2 and in human cell lines, high levels of Sp1 compared
to Sp3 activates this promoter, while an excess of Sp3 of nonepithelial genes. The combinatorial theory of gene
regulation (Britten et al., 1969) proposes that most genesover Sp1 represses the transactivation of Sp1. Similar
observations were made in studies of the E-cadherin must be regulated by multiple proteins, each of which
plays a role in the transcription of a variety of genes withpromoter, which has a single potential Sp-binding site,
and the keratin 18 promoter, which has four sites. In widely different expression patterns. The expression of
any given gene would depend on the simultaneous inter-various epithelial and fibroblast cell lines (representing
cell types in which HPV-16 is transcriptionally active or action of a specific combination of regulatory proteins, a
concept with many examples in lymphocyte-, hepatocyte-,inactive, respectively), we detected Sp1 and Sp3 and
no other Sp-factor by supershift analyses with specific and myocyte-specific gene expression (for a review see
Ernst et al., 1995). The traditional view that Sp1 is aantibodies. We have consistently found high Sp1 levels
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